by Craig Klugman, Ph.D.
My spouse and I have an ongoing conversation, really more of an argument, about one end-of-life scenario. I have stated on several occasions that being in my middle-40s, if I was struck by a serious disease (usually the disease in the scenario is cancer) with a less than 50 percent chance of survival (remission), and a course of treatment that is prolonged and painful, then I would choose not to receive treatment. Instead, I would do a lot of traveling (if able), visit with friends (if able), and then die comfortably.
I say this as a healthy, able-bodied person and as he is quick to point out, I can’t know how I would feel if I’m ever in such a situation.…
At Wednesday’s public meeting of the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission), Amy Gutmann, Ph.D., Commission Chair, announced that the Commission’s next topic would integrate education and deliberation. “I am pleased to announce that we will begin work on a new project in the coming months: a report that will integrate […]
An in-depth roundtable discussion involving both members and presenters wrapped up today’s Washington, D.C. meeting of the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission). Today’s meeting was in response to President Obama’s request, as part of the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative, that the Bioethics Commission review the ethical […]
In the fourth series of the presentations from today’s public meeting on neuroscience and related ethical issues, the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) addressed questions related to the capacity to consent to neuroscience research. The Bioethics Commission heard from two experts in the field: Jerry Menikoff, M.D., J.D., the Director […]
As it continued today’s meeting on neuroscience, the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) turned its attention to potential clinical applications and innovations that may stem from neuroscience research. President Obama asked the Bioethics Commission to consider the ethical issues associated with neuroscience as part of the BRAIN (Brain Research through […]
The Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) heard this morning from a panel of experts representing the neurotechnology sector and regulatory agencies on the ethical considerations in direct-to-consumer (DTC) sales of neurotechnologies. The Bioethics Commission is reviewing the ethical issues associated with the application of neuroscience research in response to President […]
If you will be in or near Grand Rapids, Michigan on Friday, September 5, 2014, come to Spectrum Health’s 2014 ethics conference for clinicians: “Ethics, Law and Clinical Practice” at the Calvin College Prince Conference Center.
This is a one-day symposium addressing the ethical complexities in health care today. Conference sessions and networking opportunities are designed to increase awareness and provide strategies to clinicians from all disciplines to support ethical care in a variety of settings.
Hubris to Humility: Medical Power in Medical Futility Conflicts
Thaddeus Pope, JD, PhD
Director, Health Law Institute Associate Professor of Law
Hamline University School of Law
When Parents and Providers Disagree: Understanding and Responding to Conflicts in the Care of Children
Douglas Diekema, MD, MPH
Director, Education Treuman Katz Center for
Professor of Pediatrics and Bioethics
University of Washington School of Medicine
Current Concepts in Disclosure
Kelly Saran, MS, RN, CPHRM
Administrative Director, Office of Clinical Safety
University of Michigan Health System
Humor: Finding a Balance
Judge Sara Smolenski, JD
Chief Judge, State of Michigan 63rd District Court
- Provide a forum to discuss challenges in clinical practice from an ethical perspective.
- Explore how legal considerations influence clinical and ethical decision making at the bedside in a range of clinical settings.
- Explore the interrelationship between ethics and law
- Identify ethically- and legally-informed personal, professional and institutional strategies for addressing challenging situations in clinical practice.
As part of the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative, President Obama asked the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) to “identify proactively a set of core ethical standards – both to guide neuroscience research and to address some of the ethical dilemmas that may be raised by the […]
Today the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) dives into several of the complex ethical and societal implications of neuroscience research and its applications. Today’s agenda includes sessions on cognitive enhancement, direct-to-consumer neurotechnology, clinical innovation through neuroscience research, and capacity to consent research. President Obama requested that the Bioethics Commission review […]
Welcome to the live blog for the eighteenth public meeting of the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission). The Bioethics Commission is meeting in Washington, D.C. today, August 20, 2014, from 9 a.m. to 5 p.m., ET. At this meeting, the Bioethics Commission will continue its review of the ethical issues […]